indicatedFor

P23162
predicate

Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).

Try in SPARQL

All labels observed (17)

Label Occurrences
indicatedFor canonical 186
isIndicatedFor 48
developedForIndication 8

Description generation (PDg)

The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.

Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning.  
# Instructions
Focus on describing the relationship, not the entities themselves. 
# Response Format
Begin the description with \' Indicates...\'
Input
Predicate: indicatedFor
Generated description
Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).

Sample triples (278)

Subject Object
Leqembi early-stage Alzheimer’s disease ⓘ
Spinraza pediatric patients with spinal muscular atrophy ⓘ
Spinraza adult patients with spinal muscular atrophy ⓘ
Vumerity relapsing forms of multiple sclerosis ⓘ
Vumerity relapsing-remitting multiple sclerosis ⓘ
Vumerity active secondary progressive multiple sclerosis ⓘ
Vumerity clinically isolated syndrome ⓘ
Eisai Lecanemab – Alzheimer’s disease via predicate surface "developedForIndication" ⓘ
Eisai Leqembi – Alzheimer’s disease via predicate surface "developedForIndication" ⓘ
linked to: Leqembi
Eisai Donepezil – Alzheimer’s disease via predicate surface "developedForIndication" ⓘ
linked to: Donepezil
Eisai Aricept – Alzheimer’s disease via predicate surface "developedForIndication" ⓘ
Fampyra multiple sclerosis ⓘ
Fampyra impaired walking in multiple sclerosis ⓘ
Xolair patients with positive skin test or in vitro reactivity to a perennial aeroallergen ⓘ
Xolair patients with inadequately controlled moderate to severe persistent asthma ⓘ
Xolair patients with chronic spontaneous urticaria refractory to H1-antihistamine treatment ⓘ
Darzalex multiple myeloma ⓘ
Darzalex relapsed multiple myeloma ⓘ
Darzalex refractory multiple myeloma ⓘ
Darzalex newly diagnosed multiple myeloma ⓘ
Herceptin adjuvant therapy via predicate surface "isIndicatedAs" ⓘ
Herceptin neoadjuvant therapy via predicate surface "isIndicatedAs" ⓘ
Rituxan non-Hodgkin lymphoma ⓘ
Rituxan diffuse large B-cell lymphoma ⓘ
Rituxan follicular lymphoma ⓘ
Rituxan chronic lymphocytic leukemia ⓘ
Rituxan rheumatoid arthritis ⓘ
Rituxan granulomatosis with polyangiitis ⓘ
Rituxan microscopic polyangiitis ⓘ
Rituxan pemphigus vulgaris ⓘ
Activase acute ischemic stroke ⓘ
Activase acute myocardial infarction ⓘ
Activase ST-elevation myocardial infarction ⓘ
Activase pulmonary embolism ⓘ
Activase acute massive pulmonary embolism ⓘ
Activase restoration of function to occluded central venous access devices ⓘ
Stelara adults via predicate surface "isIndicatedIn" ⓘ
Stelara pediatric patients via predicate surface "isIndicatedIn" ⓘ
Stelara plaque psoriasis via predicate surface "hasPediatricIndicationFor" ⓘ
Stelara psoriatic arthritis via predicate surface "hasPediatricIndicationFor" ⓘ
CBD Dravet syndrome via predicate surface "EpidiolexIndication" ⓘ
CBD Lennox-Gastaut syndrome via predicate surface "EpidiolexIndication" ⓘ
CBD tuberous sclerosis complex–associated seizures via predicate surface "EpidiolexIndication" ⓘ
rVSV-ZEBOV individuals at risk of exposure to Ebola virus ⓘ
mAb114 treatment of infection caused by Zaire ebolavirus ⓘ
mAb114 treatment of Ebola virus disease in adults ⓘ
mAb114 treatment of Ebola virus disease in children ⓘ
rivastigmine mild to moderate Alzheimer’s disease dementia ⓘ
rivastigmine mild to moderate dementia associated with Parkinson’s disease ⓘ
Liturgy of the Hours lay people via predicate surface "encouragedFor" ⓘ